Molecular Diagnostics for the 2019 Novel Coronavirus
Using advanced diagnostics to get a jump on the 2019 novel coronavirus
Michael Schubert | | Quick Read
As rapidly as the 2019 novel coronavirus (2019-nCoV) outbreak is growing, so too are the efforts to combat its spread using diagnostic technology. The newest player on the block? Molecular diagnostics, which aim to detect low levels of virus in the blood to yield faster, more effective infection detection. The creators of these new diagnostics hope that their tools will permit early treatment and slow the global progress of the disease. We spoke to Irene Song, Global Product Manager at diagnostic technology manufacturer GenScript, to learn more.
Read the full article now
Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Pathologist magazine